Your Twin learns with you

30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Alison Simmons

Director

University of Oxford
Country flagUnited Kingdom

Research Interests

Explore related searches

Articles (15)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Summary T cell recognition of SARS-CoV-2 antigens after vaccination and/or natural infection has played a central role in resolving SARS-CoV-2 infections and generating adaptive immune memory. However, the clinical impact of SARS-CoV-2-specific T cell responses is variable and the mechanisms underlying T cell interaction with target antigens are not fully understood. This is especially true given the virus’ rapid evolution, which leads to new variants with immune escape capacity. In this study, we used the Omicron variant as a model organism and took a systems approach to evaluate the impact of mutations on CD8+ T cell immunogenicity. We computed an immunogenicity potential score for each SARS-CoV-2 peptide antigen from the ancestral strain and Omicron, capturing both antigen presentation and T cell recognition probabilities. By comparing ancestral vs. Omicron immunogenicity scores, we reveal a divergent and heterogeneous landscape of impact for CD8+ T cell recognition of mutated targets in Omicron variants. While T cell recognition of Omicron peptides is broadly preserved, we observed mutated peptides with deteriorated immunogenicity that may assist breakthrough infection in some individuals. We then combined our scoring scheme with an in silico mutagenesis, to characterise the position- and residue-specific theoretical mutational impact on immunogenicity. While we predict many escape trajectories from the theoretical landscape of substitutions, our study suggests that Omicron mutations in T cell epitopes did not develop under cell-mediated pressure. Our study provides a generalisable platform for fostering a deeper understanding of existing and novel variant impact on antigen-specific vaccine- and/or infection-induced T cell immunity.

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (21)

Laura Stronati

Full Professor

Sapienza University of Rome

ITALY
View details

Kevin Monahan

Imperial College London

UNITED KINGDOM
View details

Chloe H. Lee

University of Oxford

UNITED KINGDOM
View details

Semir Beyaz

Principal Investigator

Cold Spring Harbor Laboratory

UNITED STATES
View details

Lori Coburn

Associate Professor

Vanderbilt University Medical Center

UNITED STATES
View details

David Ellinghaus

Professor

Kiel University

GERMANY
View details

Zoe Christoforidou

University of Oxford

UNITED KINGDOM
View details

James Lee

The Francis Crick Institute

UNITED KINGDOM
View details

Walter Bodmer

Laboratory Head

University of Oxford

UNITED KINGDOM
View details

Calliope A Dendrou

Associate Professor in Clinical Pathology and Inflammation

University of Oxford

UNITED KINGDOM
View details

Michel Georges

University of Liege

BELGIUM
View details

Jose Ordovas-Montanes

Research Faculty

Boston Children's Hospital

UNITED STATES
View details

Hashem Koohy

University of Oxford

UNITED KINGDOM
View details

Martin Fellermeyer

University of Oxford

UNITED KINGDOM
View details

Christian Tomuschat

University Medical Center Hamburg-Eppendorf

GERMANY
View details

Gordon Moran

University of Nottingham

UNITED KINGDOM
View details

Britta F. Zecher

University Medical Center Hamburg-Eppendorf

GERMANY
View details

Craig Mowat

Clinical Senior Lecturer

University of Dundee

UNITED KINGDOM
View details

Debby Laukens

Associate Professor

Ghent University

BELGIUM
View details

Tarun Gupta

NIHR Academic Clinical Lecturer in Gastroenterology

Weatherall Institute of Molecular Medicine

UNITED KINGDOM
View details

Mauro D'Amato

Professor of Medical Gentics

LUM Jean Monnet University

ITALY
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.